Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Genet Mol Res ; 12(4): 5937-44, 2013 Nov 26.
Artigo em Inglês | MEDLINE | ID: mdl-24338387

RESUMO

Carbamazepine (CBZ) is used as the first line of treatment of complex partial seizures (CPS) in Malaysia. While this drug is known to be effective for the treatment of CPS, more than 30% of patients remain drug resistant to CBZ mono-therapy. We examined a possible relationship between patients' response to CBZ mono-therapy and the G2677T SNP of the ABCB1 gene. Three hundred and fourteen patients with CPS were recruited from the Neurology Department of the Kuala Lumpur Hospital, of whom 152 were responders and the other 162 were non-responders to CBZ mono-therapy. DNA was extracted from blood samples and real-time PCR was performed to detect the G2677T SNP of the ABCB1 gene. Results were described as genotype frequencies and compared by logistic regression analysis. Among the 152 responders, 74% had the GG genotype. However, among the 162 non-responders, 26.5% had the GT genotype and 39% had the TT genotype. There was a significant difference in genotype frequency (TT vs GG; odds ratio 4.70; 95% confidence interval, 2.70-8.20) between responders and non-responders. The presence of the T allele of the G2677T SNP appears to be a useful screening marker to determine if a patient is going to be resistant to CBZ as a single drug therapy in the treatment of CPS.


Assuntos
Membro 1 da Subfamília B de Cassetes de Ligação de ATP/genética , Anticonvulsivantes/uso terapêutico , Carbamazepina/uso terapêutico , Polimorfismo de Nucleotídeo Único , Estado Epiléptico/genética , Subfamília B de Transportador de Cassetes de Ligação de ATP , Adulto , Feminino , Frequência do Gene , Estudos de Associação Genética , Humanos , Malásia , Masculino , Pessoa de Meia-Idade , Estado Epiléptico/tratamento farmacológico , Resultado do Tratamento
2.
Trop Biomed ; 32(1): 187-91, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25801270

RESUMO

Dengue serotype surveillance is important as any changes in serotype distribution may result in an outbreak or increase in severe dengue cases. This study aimed to determine circulating dengue serotypes in two hospitals in Selangor. Serum samples were collected from patients admitted for dengue at these two major public hospitals i.e. Hospital Sungai Buloh (HSB) and Hospital Tunku Ampuan Rahimah (HTAR) between November 2010 and August 2011 and subjected to real-time RT-PCR using SYBR® Green. All four dengue serotypes were detected in samples from both hospitals. The predominating serotype was dengue 1 in samples from both hospitals (HSB, DENV-1; 25.53 % and HTAR, DENV-1; 32.1 %).


Assuntos
Vírus da Dengue/classificação , Dengue/epidemiologia , Dengue/virologia , Monitoramento Epidemiológico , Sorogrupo , Vírus da Dengue/isolamento & purificação , Hospitais , Humanos , Malásia/epidemiologia , RNA Viral/genética , Reação em Cadeia da Polimerase em Tempo Real , Estudos Soroepidemiológicos , Soro/virologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA